Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Campian, Jian
163  Ergebnisse:
Personensuche X
?
1

Editorial: Radiotherapy strategies for precise treatment on..:

Lehrer, Eric J. ; Breen, William G. ; Sener, Ugur.
Frontiers in Oncology.  14 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
2

Immune Checkpoint Inhibitors and Glioblastoma: A Review on ..:

Ser, Merve Hazal ; Webb, Mason J. ; Sener, Ugur.
Journal of Immunotherapy and Precision Oncology.  7 (2024)  2 - p. 97-110 , 2024
Link: https://doi.org/10.36401..
 
?
3

A Phase 1/2 Study of Disulfiram and Copper With Concurrent ..:

Huang, Jiayi ; Campian, Jian L. ; DeWees, Todd A....
International Journal of Radiation Oncology*Biology*Physics.  , 2024
Link: https://doi.org/10.1016/..
 
?
4

Proton Craniospinal Irradiation with Immunotherapy in Two P..:

Sener, Ugur ; Webb, Mason ; Breen, William G....
Journal of Immunotherapy and Precision Oncology.  7 (2024)  1 - p. 1-6 , 2024
Link: https://doi.org/10.36401..
 
?
5

A case series of osseous metastases in patients with gliobl..:

Webb, Lauren Michelle ; Webb, Mason J. ; Campian, Jian L....
Medicine.  103 (2024)  27 - p. e38794 , 2024
Link: https://doi.org/10.1097/..
 
?
6

CTNI-73. ALLIANCE A071601: PHASE II TRIAL OF BRAF/MEK INHIB..:

Brastianos, Priscilla ; Twohy, Erin ; Geyer, Susan...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v94-v94 , 2023
Link: https://doi.org/10.1093/..
 
?
7

Teaching NeuroImage: Intracranial Solitary Fibrous Tumor Wi..:

Webb, Mason James ; Campian, Jian L. ; Sener, Ugur
Neurology.  100 (2023)  18 - p. 884-885 , 2023
Link: https://doi.org/10.1212/..
 
?
8

Proton craniospinal irradiation with bevacizumab and pembro..:

Webb, Mason J ; Breen, William G ; Laack, Nadia N...
CNS Oncology.  12 (2023)  3 - p. , 2023
Link: https://doi.org/10.2217/..
 
?
9

CTNI-03. EFFICACY OF WSD0922-FU IN OSIMERTINIB-RESISTANT NS..:

Kizilbash, Sani H ; Jaeckle, Kurt ; Mrugala, Maciej...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v73-v73 , 2023
Link: https://doi.org/10.1093/..
 
?
10

Cerebrospinal fluid 2-hydroxyglutarate as a monitoring biom..:

Riviere-Cazaux, Cecile ; Lacey, Jean M ; Carlstrom, Lucas P...
Neuro-Oncology Advances.  5 (2023)  1 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
11

Clinical, histological, and molecular features of gliomas i..:

Romo, Carlos G ; Piotrowski, Anna F ; Campian, Jian L...
Neuro-Oncology.  25 (2023)  8 - p. 1474-1486 , 2023
Link: https://doi.org/10.1093/..
 
?
12

NCOG-18. CLINICAL CHARACTERISTICS OF H3.G34 DIFFUSE HEMISPH..:

Williams, Andrew ; Neth, Bryan ; Campian, Jian...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v217-v217 , 2023
Link: https://doi.org/10.1093/..
 
?
13

Withdrawal of bevacizumab is associated with rebound growth..:

Webb, M J ; Neth, Bryan J ; Webb, Lauren M...
Neuro-Oncology Advances.  5 (2023)  1 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
14

CTIM-33. EFFICACY AND SAFETY STUDY OF NEOADJUVANT EFINEPTAK..:

Webb, Mason ; Sener, Ugur ; Burns, Terry...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v70-v70 , 2023
Link: https://doi.org/10.1093/..
 
?
15

CTNI-41. PHASE II AND PHASE 0 RESULTS OF ABTC 1801: A MULTI..:

Schiff, David ; Bindra, Ranjit S ; Li, Jing...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v84-v84 , 2023
Link: https://doi.org/10.1093/..
 
1-15